{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:11Z","timestamp":1793157911847,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12022-025-09896-7","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:04:45Z","timestamp":1767423885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["New Insights from the Expression of the Mismatch Repair System in Pituitary Neuroendocrine Tumors"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4710-9877","authenticated-orcid":false,"given":"Francesca","family":"Carbonara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6223-9952","authenticated-orcid":false,"given":"Francesca","family":"Gianno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-0064","authenticated-orcid":false,"given":"Tiziana","family":"Feola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7113-1167","authenticated-orcid":false,"given":"Francesco","family":"Mancinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5242-1761","authenticated-orcid":false,"given":"Dario","family":"De Alcubierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8730-2617","authenticated-orcid":false,"given":"Eleonora","family":"Lucantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0708-8282","authenticated-orcid":false,"given":"Antonietta","family":"Arcella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-0086","authenticated-orcid":false,"given":"Alba","family":"Di Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1643-5530","authenticated-orcid":false,"given":"Roberta","family":"Morace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9037-5417","authenticated-orcid":false,"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3727-4502","authenticated-orcid":false,"given":"Stefano","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7316-5461","authenticated-orcid":false,"given":"Vincenzo","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-8997","authenticated-orcid":false,"given":"Marie-Lise","family":"Jaffrain-Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"9896_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, Giustina A, Wass JAH, Ho KKY (2022) Clinical Biology of the Pituitary Adenoma. Endocr Rev 43:1003\u20131037. https:\/\/doi.org\/10.1210\/endrev\/bnac010","journal-title":"Endocr Rev"},{"key":"9896_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11154-020-09562-9","volume":"21","author":"J Trouillas","year":"2020","unstructured":"Trouillas J, Jaffrain-Rea M-L, Vasiljevic A, Dekkers O, Popovic V, Wierinckx A, McCormack A, Petersenn S, Burman P, Raverot G, Villa C (2020) Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician\u2019s questions. Rev Endocr Metab Disord 21:243\u2013251. https:\/\/doi.org\/10.1007\/s11154-020-09562-9","journal-title":"Rev Endocr Metab Disord"},{"key":"9896_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol 33:6\u201326. https:\/\/doi.org\/10.1007\/s12022-022-09703-7","journal-title":"Endocr Pathol"},{"key":"9896_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc3878","volume":"15","author":"HT Lynch","year":"2015","unstructured":"Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP (2015) Milestones of Lynch syndrome: 1895\u20132015. Nat Rev Cancer 15:181\u2013194. https:\/\/doi.org\/10.1038\/nrc3878","journal-title":"Nat Rev Cancer"},{"key":"9896_CR5","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1210\/jc.2012-2924","volume":"98","author":"T Hirohata","year":"2013","unstructured":"Hirohata T, Asano K, Ogawa Y, Takano S, Amano K, Isozaki O, Iwai Y, Sakata K, Fukuhara N, Nishioka H, Yamada S, Fujio S, Arita K, Takano K, Tominaga A, Hizuka N, Ikeda H, Osamura RY, Tahara S, Ishii Y, Kawamata T, Shimatsu A, Teramoto A, Matsuno A (2013) DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors. J Clin Endocrinol Metab 98:1130\u20131136. https:\/\/doi.org\/10.1210\/jc.2012-2924","journal-title":"J Clin Endocrinol Metab"},{"key":"9896_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00795-013-0050-z","volume":"47","author":"A Matsuno","year":"2014","unstructured":"Matsuno A, Murakami M, Hoya K, Yamada SM, Miyamoto S, Yamada S, Son J-H, Nishido H, Ide F, Nagashima H, Sugaya M, Hirohata T, Mizutani A, Okinaga H, Ishii Y, Tahara S, Teramoto A, Osamura RY (2014) Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide. Med Mol Morphol 47:1\u20137. https:\/\/doi.org\/10.1007\/s00795-013-0050-z","journal-title":"Med Mol Morphol"},{"key":"9896_CR7","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1210\/jc.2018-01347","volume":"103","author":"AL Lin","year":"2018","unstructured":"Lin AL, Jonsson P, Tabar V, Yang TJ, Cuaron J, Beal K, Cohen M, Postow M, Rosenblum M, Shia J, DeAngelis LM, Taylor BS, Young RJ, Geer EB (2018) Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab. J Clin Endocrinol Metab 103:3925\u20133930. https:\/\/doi.org\/10.1210\/jc.2018-01347","journal-title":"J Clin Endocrinol Metab"},{"key":"9896_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/CAD.0000000000000856","volume":"31","author":"M Caccese","year":"2020","unstructured":"Caccese M, Barbot M, Ceccato F, Padovan M, Gardiman MP, Fassan M, Denaro L, Emanuelli E, D\u2019Avella D, Scaroni C, Zagonel V, Lombardi G (2020) Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab. Anticancer Drugs 31:199\u2013204. https:\/\/doi.org\/10.1097\/CAD.0000000000000856","journal-title":"Anticancer Drugs"},{"key":"9896_CR9","doi-asserted-by":"publisher","first-page":"e001532","DOI":"10.1136\/jitc-2020-001532","volume":"8","author":"N Majd","year":"2020","unstructured":"Majd N, Waguespack SG, Janku F, Fu S, Penas-Prado M, Xu M, Alshawa A, Kamiya-Matsuoka C, Raza SM, McCutcheon IE, Naing A (2020) Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study. J Immunother Cancer 8:e001532. https:\/\/doi.org\/10.1136\/jitc-2020-001532","journal-title":"J Immunother Cancer"},{"key":"9896_CR10","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/JCO.22.02331","volume":"41","author":"MA Shah","year":"2023","unstructured":"Shah MA, Kennedy EB, Alarcon-Rozas AE, Alcindor T, Bartley AN, Malowany AB, Bhadkamkar NA, Deighton DC, Janjigian Y, Karippot A, Khan U, King DA, Klute K, Lacy J, Lee JJ, Mehta R, Mukherjee S, Nagarajan A, Park H, Saeed A, Semrad TJ, Shitara K, Smyth E, Uboha NV, Vincelli M, Wainberg Z, Rajdev L (2023) Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline. J Clin Oncol Off J Am Soc Clin Oncol 41:1470\u20131491. https:\/\/doi.org\/10.1200\/JCO.22.02331","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"9896_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1507\/endocrj.EJ17-0036","volume":"64","author":"S Uraki","year":"2017","unstructured":"Uraki S, Ariyasu H, Doi A, Furuta H, Nishi M, Sugano K, Inoshita N, Nakao N, Yamada S, Akamizu T (2017) Atypical pituitary adenoma with MEN1 somatic mutation associated with abnormalities of DNA mismatch repair genes; MLH1 germline mutation and MSH6 somatic mutation. Endocr J 64:895\u2013906. https:\/\/doi.org\/10.1507\/endocrj.EJ17-0036","journal-title":"Endocr J"},{"key":"9896_CR12","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1210\/jc.2017-01401","volume":"102","author":"D Bengtsson","year":"2017","unstructured":"Bengtsson D, Joost P, Aravidis C, Askmalm Stenmark M, Backman A-S, Melin B, von Salom\u00e9 J, Zagoras T, Gebre-Medhin S, Burman P (2017) Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort. J Clin Endocrinol Metab 102:3928\u20133932. https:\/\/doi.org\/10.1210\/jc.2017-01401","journal-title":"J Clin Endocrinol Metab"},{"key":"9896_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cancergen.2021.03.008","volume":"256\u2013257","author":"PB Loughrey","year":"2021","unstructured":"Loughrey PB, Baker G, Herron B, Cooke S, Iacovazzo D, Lindsay JR, Korbonits M (2021) Invasive ACTH-producing pituitary gland neoplasm secondary to MSH2 mutation. Cancer Genet 256\u2013257:36\u201339. https:\/\/doi.org\/10.1016\/j.cancergen.2021.03.008","journal-title":"Cancer Genet"},{"key":"9896_CR14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/02688697.2021.1967881","volume":"38","author":"J Teuber","year":"2024","unstructured":"Teuber J, Reinhardt A, Reuss D, H\u00e4hnel S, Unterberg A, Beynon C (2024) Aggressive pituitary adenoma in the context of Lynch syndrome: a case report and literature review on this rare coincidence. Br J Neurosurg 38:775\u2013780. https:\/\/doi.org\/10.1080\/02688697.2021.1967881","journal-title":"Br J Neurosurg"},{"key":"9896_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1210\/jc.2017-02332","volume":"103","author":"S Uraki","year":"2018","unstructured":"Uraki S, Ariyasu H, Doi A, Kawai S, Takeshima K, Morita S, Fukai J, Fujita K, Furuta H, Nishi M, Sugano K, Inoshita N, Nakao N, Yamada S, Akamizu T (2018) Reduced Expression of Mismatch Repair Genes MSH6\/MSH2 Directly Promotes Pituitary Tumor Growth via the ATR-Chk1 Pathway. J Clin Endocrinol Metab 103:1171\u20131179. https:\/\/doi.org\/10.1210\/jc.2017-02332","journal-title":"J Clin Endocrinol Metab"},{"key":"9896_CR16","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.3390\/ijms21082831","volume":"21","author":"S Uraki","year":"2020","unstructured":"Uraki S, Ariyasu H, Doi A, Takeshima K, Morita S, Inaba H, Furuta H, Fukuhara N, Inoshita N, Nishioka H, Nakao N, Yamada S, Akamizu T (2020) MSH6\/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes. Int J Mol Sci 21:2831. https:\/\/doi.org\/10.3390\/ijms21082831","journal-title":"Int J Mol Sci"},{"key":"9896_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","volume":"475","author":"C Villa","year":"2019","unstructured":"Villa C, Vasiljevic A, Jaffrain-Rea ML, Ansorge O, Asioli S, Barresi V, Chinezu L, Gardiman MP, Lania A, Lapshina AM, Poliani L, Reiniger L, Righi A, Saeger W, Soukup J, Theodoropoulou M, Uccella S, Trouillas J, Roncaroli F (2019) A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal. Virchows Arch Int J Pathol 475:687\u2013692. https:\/\/doi.org\/10.1007\/s00428-019-02655-0","journal-title":"Virchows Arch Int J Pathol"},{"key":"9896_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1677\/JOE-07-0020","volume":"194","author":"A Fratticci","year":"2007","unstructured":"Fratticci A, Grieco FA, Spilioti C, Giangaspero F, Ventura L, Esposito V, Piccirilli M, Santoro A, Gulino A, Cantore G, Alesse E, Jaffrain-Rea ML (2007) Differential expression of neurogenins and NeuroD1 in human pituitary tumours. J Endocrinol 194:475\u2013484. https:\/\/doi.org\/10.1677\/JOE-07-0020","journal-title":"J Endocrinol"},{"key":"9896_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2559.2010.03485.x","volume":"56","author":"E Barrow","year":"2010","unstructured":"Barrow E, Jagger E, Brierley J, Wallace A, Evans G, Hill J, McMahon R (2010) Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome. Histopathology 56:331\u2013344. https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03485.x","journal-title":"Histopathology"},{"key":"9896_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1530\/ERC-12-0322","volume":"20","author":"M-L Jaffrain-Rea","year":"2013","unstructured":"Jaffrain-Rea M-L, Rotondi S, Turchi A, Occhi G, Barlier A, Peverelli E, Rostomyan L, Defilles C, Angelini M, Oliva M-A, Ceccato F, Maiorani O, Daly AF, Esposito V, Buttarelli F, Figarella-Branger D, Giangaspero F, Spada A, Scaroni C, Alesse E, Beckers A (2013) Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations. Endocr Relat Cancer 20:753\u2013766. https:\/\/doi.org\/10.1530\/ERC-12-0322","journal-title":"Endocr Relat Cancer"},{"key":"9896_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1210\/js.2017-00364","volume":"2","author":"C Ballmann","year":"2018","unstructured":"Ballmann C, Thiel A, Korah HE, Reis A-C, Saeger W, Stepanow S, K\u00f6hrer K, Reifenberger G, Knobbe-Thomsen CB, Knappe UJ, Scholl UI (2018) USP8 Mutations in Pituitary Cushing Adenomas-Targeted Analysis by Next-Generation Sequencing. J Endocr Soc 2:266\u2013278. https:\/\/doi.org\/10.1210\/js.2017-00364","journal-title":"J Endocr Soc"},{"key":"9896_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/neuonc\/noz109","volume":"21","author":"S Sbiera","year":"2019","unstructured":"Sbiera S, Perez-Rivas LG, Taranets L, Weigand I, Flitsch J, Graf E, Monoranu C-M, Saeger W, Hagel C, Honegger J, Assie G, Hermus AR, Stalla GK, Herterich S, Ronchi CL, Deutschbein T, Reincke M, Strom TM, Popov N, Theodoropoulou M, Fassnacht M (2019) Driver mutations in USP8 wild-type Cushing\u2019s disease. Neuro-Oncol 21:1273\u20131283. https:\/\/doi.org\/10.1093\/neuonc\/noz109","journal-title":"Neuro-Oncol"},{"key":"9896_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M (2015) Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat Genet 47:31\u201338. https:\/\/doi.org\/10.1038\/ng.3166","journal-title":"Nat Genet"},{"key":"9896_CR24","doi-asserted-by":"publisher","unstructured":"Tessitore A, Bruera G, Mastroiaco V, Cannita K, Cortellini A, Cocciolone V, Dal Mas A, Calvisi G, Zazzeroni F, Ficorella C, Ricevuto E, Alesse E (2018) KRAS and 2 rare PI3KCA mutations coexisting in a metastatic colorectal cancer patient with aggressive and resistant disease. Hum Pathol 74:178\u2013182. https:\/\/doi.org\/10.1016\/j.humpath.2018.01.021","DOI":"10.1016\/j.humpath.2018.01.021"},{"key":"9896_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/ejendo\/lvad114","volume":"189","author":"J Simon","year":"2023","unstructured":"Simon J, Perez-Rivas LG, Zhao Y, Chasseloup F, Lasolle H, Cortet C, Descotes F, Villa C, Baussart B, Burman P, Maiter D, von Selzam V, Rotermund R, Flitsch J, Thorsteinsdottir J, Jouanneau E, Buchfelder M, Chanson P, Raverot G, Theodoropoulou M (2023) Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours. Eur J Endocrinol 189:372\u2013378. https:\/\/doi.org\/10.1093\/ejendo\/lvad114","journal-title":"Eur J Endocrinol"},{"key":"9896_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0002-9440(10)63878-3","volume":"162","author":"S-J Park","year":"2003","unstructured":"Park S-J, Rashid A, Lee J-H, Kim SG, Hamilton SR, Wu T-T (2003) Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162:815\u2013822. https:\/\/doi.org\/10.1016\/S0002-9440(10)63878-3","journal-title":"Am J Pathol"},{"key":"9896_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0378-1119(98)00187-5","volume":"213","author":"Y Iwahashi","year":"1998","unstructured":"Iwahashi Y, Ito E, Yanagisawa Y, Akiyama Y, Yuasa Y, Onodera T, Maruyama K (1998) Promoter analysis of the human mismatch repair gene hMSH2. Gene 213:141\u2013147. https:\/\/doi.org\/10.1016\/s0378-1119(98)00187-5","journal-title":"Gene"},{"key":"9896_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/gcc.1211","volume":"33","author":"M Szadkowski","year":"2002","unstructured":"Szadkowski M, Jiricny J (2002) Identification and functional characterization of the promoter region of the human MSH6 gene. Genes Chromosomes Cancer 33:36\u201346. https:\/\/doi.org\/10.1002\/gcc.1211","journal-title":"Genes Chromosomes Cancer"},{"key":"9896_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson M-L, Septier A, Letourneur F, Diry S, Diedisheim M, Izac B, Gaspar C, Perlemoine K, Verjus V, Bernier M, Boulin A, Emile J-F, Bertagna X, Jaffrezic F, Laloe D, Baussart B, Bertherat J, Gaillard S, Assi\u00e9 G (2020) Pangenomic Classification of Pituitary Neuroendocrine Tumors. Cancer Cell 37:123\u2013134.e5. https:\/\/doi.org\/10.1016\/j.ccell.2019.11.002","journal-title":"Cancer Cell"},{"key":"9896_CR30","doi-asserted-by":"publisher","first-page":"19373","DOI":"10.1038\/s41598-020-76555-8","volume":"10","author":"K Taniguchi-Ponciano","year":"2020","unstructured":"Taniguchi-Ponciano K, Andonegui-Elguera S, Pe\u00f1a-Mart\u00ednez E, Silva-Rom\u00e1n G, Vela-Pati\u00f1o S, Gomez-Apo E, Chavez-Macias L, Vargas-Ortega G, Espinosa-de-los-Monteros L, Gonzalez-Virla B, Perez C, Ferreira-Hermosillo A, Espinosa-Cardenas E, Ramirez-Renteria C, Sosa E, Lopez-Felix B, Guinto G, Marrero-Rodr\u00edguez D, Mercado M (2020) Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors. Sci Rep 10:19373. https:\/\/doi.org\/10.1038\/s41598-020-76555-8","journal-title":"Sci Rep"},{"key":"9896_CR31","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/neuonc\/noab102","volume":"23","author":"Y Cui","year":"2021","unstructured":"Cui Y, Li C, Jiang Z, Zhang S, Li Q, Liu X, Zhou Y, Li R, Wei L, Li L, Zhang Q, Wen L, Tang F, Zhou D (2021) Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors. Neuro-Oncol 23:1859\u20131871. https:\/\/doi.org\/10.1093\/neuonc\/noab102","journal-title":"Neuro-Oncol"},{"key":"9896_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/cjp2.120","volume":"5","author":"AJ McCarthy","year":"2019","unstructured":"McCarthy AJ, Capo-Chichi J-M, Spence T, Grenier S, Stockley T, Kamel-Reid S, Serra S, Sabatini P, Chetty R (2019) Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation. J Pathol Clin Res 5:115\u2013129. https:\/\/doi.org\/10.1002\/cjp2.120","journal-title":"J Pathol Clin Res"},{"key":"9896_CR33","doi-asserted-by":"publisher","first-page":"103822","DOI":"10.1016\/j.dnarep.2025.103822","volume":"147","author":"JT DeWitt","year":"2025","unstructured":"DeWitt JT, Jimenez-Tovar D, Mazumder A, Haricharan S (2025) Advances in diagnostic and therapeutic applications of mismatch repair loss in cancer. DNA Repair 147:103822. https:\/\/doi.org\/10.1016\/j.dnarep.2025.103822","journal-title":"DNA Repair"},{"key":"9896_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10689-016-9882-8","volume":"15","author":"P Peltom\u00e4ki","year":"2016","unstructured":"Peltom\u00e4ki P (2016) Update on Lynch syndrome genomics. Fam Cancer 15:385\u2013393. https:\/\/doi.org\/10.1007\/s10689-016-9882-8","journal-title":"Fam Cancer"},{"key":"9896_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12022-020-09612-7","volume":"31","author":"C Fraune","year":"2020","unstructured":"Fraune C, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, B\u00fcscheck F, Amin T, Viol F, Fehrle W, Dum D, H\u00f6flmayer D, Burandt E, Clauditz TS, Perez D, Izbicki J, Wilczak W, Sauter G, Steurer S, Schrader J (2020) Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas. Endocr Pathol 31:182\u2013189. https:\/\/doi.org\/10.1007\/s12022-020-09612-7","journal-title":"Endocr Pathol"},{"key":"9896_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1530\/EJE-22-0440","volume":"187","author":"P Burman","year":"2022","unstructured":"Burman P, Trouillas J, Losa M, McCormack A, Petersenn S, Popovic V, Theodoropoulou M, Raverot G, Dekkers OM, ESE survey collaborators \u2020 (2022) Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients. Eur J Endocrinol 187:593\u2013605. https:\/\/doi.org\/10.1530\/EJE-22-0440","journal-title":"Eur J Endocrinol"},{"key":"9896_CR37","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cancers12041012","volume":"12","author":"MD Ilie","year":"2020","unstructured":"Ilie MD, Vasiljevic A, Louvet C, Jouanneau E, Raverot G (2020) Gonadotroph Tumors Show Subtype Differences That Might Have Implications for Therapy. Cancers 12:1012. https:\/\/doi.org\/10.3390\/cancers12041012","journal-title":"Cancers"},{"key":"9896_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12022-023-09794-w","volume":"35","author":"F Carbonara","year":"2024","unstructured":"Carbonara F, Feola T, Gianno F, Polidoro MA, Di Crescenzo RM, Arcella A, De Angelis M, Morace R, de Alcubierre D, Esposito V, Giangaspero F, Jaffrain-Rea M-L (2024) Clinical and Molecular Characteristics of Gonadotroph Pituitary Tumors According to the WHO Classification. Endocr Pathol 35:1\u201313. https:\/\/doi.org\/10.1007\/s12022-023-09794-w","journal-title":"Endocr Pathol"},{"key":"9896_CR39","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41598-018-19704-4","volume":"8","author":"V Peshdary","year":"2018","unstructured":"Peshdary V, Atlas E (2018) Dexamethasone induced miR-155 up-regulation in differentiating 3T3-L1 preadipocytes does not affect adipogenesis. Sci Rep 8:1264. https:\/\/doi.org\/10.1038\/s41598-018-19704-4","journal-title":"Sci Rep"},{"key":"9896_CR40","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.1073\/pnas.1002472107","volume":"107","author":"N Valeri","year":"2010","unstructured":"Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo GJ, Alder H, Gafa R, Calore F, Ferracin M, Lanza G, Volinia S, Negrini M, McIlhatton MA, Amadori D, Fishel R, Croce CM (2010) Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A 107:6982. https:\/\/doi.org\/10.1073\/pnas.1002472107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9896_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12022-021-09702-0","volume":"33","author":"H Alzoubi","year":"2022","unstructured":"Alzoubi H, Minasi S, Gianno F, Antonelli M, Belardinilli F, Giangaspero F, Jaffrain-Rea M-L, Buttarelli FR (2022) Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors. Endocr Pathol 33:494\u2013505. https:\/\/doi.org\/10.1007\/s12022-021-09702-0","journal-title":"Endocr Pathol"},{"key":"9896_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/biology13030171","volume":"13","author":"M Sbaffone","year":"2024","unstructured":"Sbaffone M, Jaffrain-Rea M-L, Cappabianca L, Carbonara F, Gianno F, Feola T, Ruggieri M, Zelli V, Maccarone R, Guadagni S, Clementi M, Arcella A, Esposito V, Carozza G, Martelli I, Farina AR, Mackay AR (2024) A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression. Biology 13:171. https:\/\/doi.org\/10.3390\/biology13030171","journal-title":"Biology"},{"key":"9896_CR43","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1210\/clinem\/dgaa853","volume":"106","author":"AV Uzilov","year":"2021","unstructured":"Uzilov AV, Taik P, Cheesman KC, Javanmard P, Ying K, Roehnelt A, Wang H, Fink MY, Lau CY, Moe AS, Villar J, Bederson JB, Stewart AF, Donovan MJ, Mahajan M, Sebra R, Post KD, Chen R, Geer EB (2021) USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors. J Clin Endocrinol Metab 106:826\u2013842. https:\/\/doi.org\/10.1210\/clinem\/dgaa853","journal-title":"J Clin Endocrinol Metab"},{"key":"9896_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40478-022-01437-1","volume":"10","author":"LG Perez-Rivas","year":"2022","unstructured":"Perez-Rivas LG, Simon J, Albani A, Tang S, Roeber S, Assi\u00e9 G, Deutschbein T, Fassnacht M, Gadelha MR, Hermus AR, Stalla GK, Tichomirowa MA, Rotermund R, Flitsch J, Buchfelder M, Nasi-Kordhishti I, Honegger J, Thorsteinsdottir J, Saeger W, Herms J, Reincke M, Theodoropoulou M (2022) TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome. Acta Neuropathol Commun 10:139. https:\/\/doi.org\/10.1186\/s40478-022-01437-1","journal-title":"Acta Neuropathol Commun"},{"key":"9896_CR45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11102-022-01253-9","volume":"25","author":"M Theodoropoulou","year":"2022","unstructured":"Theodoropoulou M, Reincke M (2022) Genetics of Cushing\u2019s disease: from the lab to clinical practice. Pituitary 25:689\u2013692. https:\/\/doi.org\/10.1007\/s11102-022-01253-9","journal-title":"Pituitary"},{"key":"9896_CR46","doi-asserted-by":"publisher","first-page":"E1761-1767","DOI":"10.1227\/NEU.0b013e318217161a","volume":"68","author":"M Murakami","year":"2011","unstructured":"Murakami M, Mizutani A, Asano S, Katakami H, Ozawa Y, Yamazaki K, Ishida Y, Takano K, Okinaga H, Matsuno A (2011) A mechanism of acquiring temozolomide resistance during transformation of atypical prolactinoma into prolactin-producing pituitary carcinoma: case report. Neurosurgery 68:E1761-1767; discussion E1767. https:\/\/doi.org\/10.1227\/NEU.0b013e318217161a","journal-title":"Neurosurgery"},{"key":"9896_CR47","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/s41467-020-16052-8","volume":"11","author":"C Li","year":"2020","unstructured":"Li C, Xie W, Rosenblum JS, Zhou J, Guo J, Miao Y, Shen Y, Wang H, Gong L, Li M, Zhao S, Cheng S, Zhu H, Jiang T, Ling S, Wang F, Zhang H, Zhang M, Qu Y, Zhang Q, Li G, Wang J, Ma J, Zhuang Z, Zhang Y (2020) Somatic SF3B1 hotspot mutation in prolactinomas. Nat Commun 11:2506. https:\/\/doi.org\/10.1038\/s41467-020-16052-8","journal-title":"Nat Commun"},{"key":"9896_CR48","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41379-022-01149-w","volume":"35","author":"KTS Aiyer","year":"2022","unstructured":"Aiyer KTS, Doeleman T, Ryan NA, Nielsen M, Crosbie EJ, Smit VTHBM, Morreau H, Goeman JJ, Bosse T (2022) Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis. Mod Pathol Off J U S Can Acad Pathol Inc 35:1775\u20131783. https:\/\/doi.org\/10.1038\/s41379-022-01149-w","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"9896_CR49","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.3390\/cancers14174093","volume":"14","author":"T Feola","year":"2022","unstructured":"Feola T, Carbonara F, Verrico M, Di Crescenzo RM, Gianno F, Colonnese C, Arcella A, de Alcubierre D, Tomao S, Esposito V, Giangaspero F, Minniti G, Jaffrain-Rea M-L (2022) Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art. Cancers 14:4093. https:\/\/doi.org\/10.3390\/cancers14174093","journal-title":"Cancers"},{"key":"9896_CR50","doi-asserted-by":"publisher","first-page":"bvae085","DOI":"10.1210\/jendso\/bvae085","volume":"8","author":"AS Alzahrani","year":"2024","unstructured":"Alzahrani AS, Bin Nafisah A, Alswailem M, Alghamdi B, Alsaihati B, Aljafar H, Baz B, Alhindi H, Moria Y, Butt MI, Alkabbani AG, Alshaikh OM, Alnassar A, Bin Afeef A, AlQuraa R, Alsuhaibani R, Alhadlaq O, Abothenain F, Altwaijry YA (2024) Germline Variants in Sporadic Pituitary Adenomas. J Endocr Soc 8:bvae085. https:\/\/doi.org\/10.1210\/jendso\/bvae085","journal-title":"J Endocr Soc"},{"key":"9896_CR51","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","volume":"24","author":"MP Salomon","year":"2018","unstructured":"Salomon MP, Wang X, Marzese DM, Hsu SC, Nelson N, Zhang X, Matsuba C, Takasumi Y, Ballesteros-Merino C, Fox BA, Barkhoudarian G, Kelly DF, Hoon DSB (2018) The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing\u2019s Disease and Endocrine-Inactive Subtypes. Clin Cancer Res Off J Am Assoc Cancer Res 24:4126\u20134136. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2206","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"9896_CR52","doi-asserted-by":"publisher","unstructured":"Pat\u00f3cs A, Nagy P, Papp J, Bozsik A, Antal B, Grolmusz VK, P\u00f3cza T, Butz H (2024) Cost-effectiveness of genetic testing of endocrine tumor patients using a comprehensive hereditary cancer gene panel. J Clin Endocrinol Metab dgae300. https:\/\/doi.org\/10.1210\/clinem\/dgae300","DOI":"10.1210\/clinem\/dgae300"},{"key":"9896_CR53","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EO-21-0033","volume":"2","author":"S Pekic","year":"2022","unstructured":"Pekic S, Stojanovic M, Popovic V (2022) Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal? Endocr Oncol Bristol Engl 2:R1\u2013R13. https:\/\/doi.org\/10.1530\/EO-21-0033","journal-title":"Endocr Oncol Bristol Engl"},{"key":"9896_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/ijms26020531","volume":"26","author":"MW M\u00f8ller","year":"2025","unstructured":"M\u00f8ller MW, Nortvig MJ, Andersen MS, Poulsen FR (2025) DNA Methylation in Pituitary Adenomas: A Scoping Review. Int J Mol Sci 26:531. https:\/\/doi.org\/10.3390\/ijms26020531","journal-title":"Int J Mol Sci"},{"key":"9896_CR55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/CEG.S278054","volume":"14","author":"C Therkildsen","year":"2021","unstructured":"Therkildsen C, Jensen LH, Rasmussen M, Bernstein I (2021) An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome. Clin Exp Gastroenterol 14:181\u2013197. https:\/\/doi.org\/10.2147\/CEG.S278054","journal-title":"Clin Exp Gastroenterol"},{"key":"9896_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.trecan.2016.02.004","volume":"2","author":"M Kloor","year":"2016","unstructured":"Kloor M, von Knebel Doeberitz M (2016) The Immune Biology of Microsatellite-Unstable Cancer. Trends Cancer 2:121\u2013133. https:\/\/doi.org\/10.1016\/j.trecan.2016.02.004","journal-title":"Trends Cancer"},{"key":"9896_CR57","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvaf100","volume":"192","author":"G Raverot","year":"2025","unstructured":"Raverot G, Burman P, Abreu AP, Heaney AP, van Hulsteijn L, Lin AL, Marcus H, McCormack A, Minniti G, Petersenn S, Popovic V, Theodoropoulou M, Trouillas J, Dekkers OM (2025) Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas. Eur J Endocrinol 192:G1\u2013G34. https:\/\/doi.org\/10.1093\/ejendo\/lvaf100","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09896-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-025-09896-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-025-09896-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T18:03:24Z","timestamp":1767463404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-025-09896-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9896"],"URL":"https:\/\/doi.org\/10.1007\/s12022-025-09896-7","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed according to the guidelines of the Declaration of Helsinki and approved by the Internal Review Board of the Neuromed IRCCS (Pozzilli, Italy)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}